275 related articles for article (PubMed ID: 22328718)
41. Changes in temperature have opposing effects on current amplitude in α7 and α4β2 nicotinic acetylcholine receptors.
Jindrichova M; Lansdell SJ; Millar NS
PLoS One; 2012; 7(2):e32073. PubMed ID: 22359659
[TBL] [Abstract][Full Text] [Related]
42. Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine.
Papke RL; Kem WR; Soti F; López-Hernández GY; Horenstein NA
J Pharmacol Exp Ther; 2009 May; 329(2):791-807. PubMed ID: 19223664
[TBL] [Abstract][Full Text] [Related]
43. New quinoline derivatives as nicotinic receptor modulators.
Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
[TBL] [Abstract][Full Text] [Related]
44. Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons.
Hu M; Gopalakrishnan M; Li J
Br J Pharmacol; 2009 Dec; 158(8):1857-64. PubMed ID: 20050184
[TBL] [Abstract][Full Text] [Related]
45. Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of α7 nicotinic acetylcholine receptors.
Thomsen MS; Mikkelsen JD
J Neurochem; 2012 Oct; 123(1):73-83. PubMed ID: 22804734
[TBL] [Abstract][Full Text] [Related]
46. Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators.
Manetti D; Dei S; Arias HR; Braconi L; Gabellini A; Teodori E; Romanelli MN
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770942
[TBL] [Abstract][Full Text] [Related]
47. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
Hamouda AK; Deba F; Wang ZJ; Cohen JB
Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
[TBL] [Abstract][Full Text] [Related]
48. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
[TBL] [Abstract][Full Text] [Related]
49. Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.
Briggs CA; Grønlien JH; Curzon P; Timmermann DB; Ween H; Thorin-Hagene K; Kerr P; Anderson DJ; Malysz J; Dyhring T; Olsen GM; Peters D; Bunnelle WH; Gopalakrishnan M
Br J Pharmacol; 2009 Nov; 158(6):1486-94. PubMed ID: 19845675
[TBL] [Abstract][Full Text] [Related]
50. Electrophysiological investigation of the effect of structurally different bispyridinium non-oxime compounds on human α7-nicotinic acetylcholine receptor activity-An in vitro structure-activity analysis.
Scheffel C; Niessen KV; Rappenglück S; Wanner KT; Thiermann H; Worek F; Seeger T
Toxicol Lett; 2018 Sep; 293():157-166. PubMed ID: 29191791
[TBL] [Abstract][Full Text] [Related]
51. Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.
Pandya AA; Yakel JL
Biochem Pharmacol; 2013 Oct; 86(8):1054-62. PubMed ID: 23732296
[TBL] [Abstract][Full Text] [Related]
52. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
[TBL] [Abstract][Full Text] [Related]
53. Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor.
Li Q; Nemecz Á; Aymé G; Dejean de la Bâtie G; Prevost MS; Pons S; Barilone N; Baachaoui R; Maskos U; Lafaye P; Corringer PJ
Cell Mol Life Sci; 2023 May; 80(6):164. PubMed ID: 37231269
[TBL] [Abstract][Full Text] [Related]
54. Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats.
Thomsen MS; El-Sayed M; Mikkelsen JD
PLoS One; 2011; 6(11):e27014. PubMed ID: 22096516
[TBL] [Abstract][Full Text] [Related]
55. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
[TBL] [Abstract][Full Text] [Related]
56. N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists.
Criado M; Mulet J; Sala F; Sala S; Colmena I; Gandía L; Bautista-Aguilera OM; Samadi A; Chioua M; Marco-Contelles J
ACS Chem Neurosci; 2016 Aug; 7(8):1157-65. PubMed ID: 27254782
[TBL] [Abstract][Full Text] [Related]
57. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
[TBL] [Abstract][Full Text] [Related]
58. Stable desensitization of α
Pismataro MC; Horenstein NA; Stokes C; Dallanoce C; Thakur GA; Papke RL
Eur J Pharmacol; 2021 Aug; 905():174179. PubMed ID: 34004208
[TBL] [Abstract][Full Text] [Related]
59. Silent agonists for α7 nicotinic acetylcholine receptors.
Papke RL; Quadri M; Gulsevin A
Pharmacol Res; 2023 Apr; 190():106736. PubMed ID: 36940890
[TBL] [Abstract][Full Text] [Related]
60. Chemical conversion of nicotinamide into type I positive allosteric modulator of α7 nAChRs.
Li X; Xie W; Wang X; Huang Z; Bian X; Wang K; Sun Q
Bioorg Med Chem Lett; 2019 Aug; 29(15):1928-1933. PubMed ID: 31153804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
